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Abstract
Snakebite envenoming is a major neglected tropical disease that affects millions of people
every year. The only effective treatment against snakebite envenoming consists of unspeci-
fied cocktails of polyclonal antibodies purified from the plasma of immunized production ani-
mals. Currently, little data exists on the molecular interactions between venom-toxin
epitopes and antivenom-antibody paratopes. To address this issue, high-density peptide
microarray (hdpm) technology has recently been adapted to the field of toxinology. How-
ever, analysis of such valuable datasets requires expert understanding and, thus, compli-
cates its broad application within the field. In the present study, we developed a user-
friendly, and high-throughput web application named “Snake Toxin and Antivenom Binding
Profiles” (STAB Profiles), to allow straight-forward analysis of hdpm datasets. To test our
tool and evaluate its performance with a large dataset, we conducted hdpm assays using all
African snake toxin protein sequences available in the UniProt database at the time of study
design, together with eight commercial antivenoms in clinical use in Africa, thus represent-
ing the largest venom-antivenom dataset to date. Furthermore, we introduced a novel
method for evaluating raw signals from a peptide microarray experiment and a data normali-
zation protocol enabling intra-microarray and even inter-microarray chip comparisons.
Finally, these data, alongside all the data from previous similar studies by Engmark et al.,
were preprocessed according to our newly developed protocol and made publicly available
for download through the STAB Profiles web application (http://tropicalpharmacology.com/
tools/stab-profiles/). With these data and our tool, we were able to gain key insights into
toxin-antivenom interactions and were able to differentiate the ability of different antivenoms
to interact with certain toxins of interest.
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The data, as well as the web application, we present in this article should be of significant
value to the venom-antivenom research community. Knowledge gained from our current
and future analyses of this dataset carry the potential to guide the improvement and optimi-
zation of current antivenoms for maximum patient benefit, as well as aid the development of
next-generation antivenoms.
Author summary
Millions of people are bitten by venomous snakes each year, resulting in over 100,000
deaths. Currently, such envenomings are treated with animal derived antivenoms that
contain undefined antibodies against snake venom toxins that have been raised by the
production animal’s immune system. To date, our understanding of these antibody toxin
interactions is sparse, but with the help of high-density peptide microarray (hdpm) tech-
nology this is starting to change. Whilst this technology is very powerful, analysis of the
output data is complex and requires expert training. Therefore, in this study, we devel-
oped a user-friendly, and high-throughput web application named “Snake Toxin and
Antivenom Binding Profiles” (STAB Profiles). Furthermore, we ensured our tool was
functional and able to handle large amounts of data by creating an entirely novel and
larger than ever hdpm dataset based on all African snake toxin proteins together with
eight commercial antivenoms. With these data and our tool, we were able to further our
understanding on toxin-antivenom interactions and were able to differentiate the ability
of different antivenoms to interact with certain toxins of interest. Ideally, these and future
insights can help guide the improvement and optimization of current antivenoms, as well
as aid the informed development of next-generation antivenoms.
Introduction
An urgent demand exists for addressing the global public health burden of snakebite enven-
oming, a neglected tropical disease that each year exacts a death toll of more than 100,000 and
leaves many more disfigured for life [1, 2]. When administered promptly, antivenoms derived
from the plasma of hyper-immunized animals are effective in neutralizing the main clinical
manifestations of snakebite envenoming, particularly the systemic effects [2–4]. Despite this,
antivenoms have many limitations relating to their specificity, safety and affordability, and
thus there is a strong rationale to develop new snakebite therapeutics with higher efficacy and
broader species coverage, as well as at a lowered cost [5, 6]. Toxicovenomics is a proteomics-
based approach that can be used to analyze snake venoms to provide an overview of which tox-
ins are medically relevant in envenomings, and this approach shows promise for selecting the
most effective venom mixtures for immunization [7–9]. However, toxicovenomics needs to be
combined with complementary analytical approaches, such as animal-based neutralization
assays, immunochemical studies [3], and antivenomics [10]; these, together, can provide an
in-depth view into the molecular reactivity and potential neutralization of these medically rele-
vant toxins [11, 12]. Nevertheless, all of these approaches fail to provide information about the
specific binding interactions between venom toxin epitopes and antivenom antibody para-
topes [11]. Such molecular interaction information is key towards developing a better under-
standing of the nature of antivenom cross-reactivity and para-specificity and, consequently,
the development of improved and broadly neutralizing antivenoms [11, 12].
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To address this issue and to facilitate high-throughput assessment of molecular interactions
between venom toxin epitopes and antivenom antibody paratopes, high-density peptide
microarray (hdpm) technology has recently been adapted to the field of toxinology [13–15].
Hdpms have long been successfully applied to a range of fields, such as enzyme inhibition,
immunoassays, affinity agents for viruses, and therapeutic peptides amongst others [16]. How-
ever, the application of this technology to venom and antivenom research is relatively new
[13]. Still, its recent introduction has already enabled the simultaneous analysis of a large num-
ber of toxins and multiple antivenoms, facilitated the identification of amino acid specific
interaction sites, and provided information about shared recognition sites between homolo-
gous toxins. Indeed, Engmark et al. demonstrated how toxin epitopes recognized by anti-
venom antibodies could be identified for toxins from multiple mamba (Dendroaspis genus)
and cobra (Naja genus) species endemic to sub-Saharan Africa [13], while a subsequent study
identified and characterized linear elements of epitopes from 870 pit viper venom (Crotalinae
subfamily) protein sequences from three major snake toxin families (snake venom metallopro-
teases [SVMPs], phospholipases A2 [PLA2s], and snake venom serine proteases [SVSPs]) [14].
In the most recent study, Engmark et al. identified the antibody-recognized epitope in short
neurotoxin 1 from black mamba (Dendroaspis polylepis) venom and explored the degree of
cross-reactivity across 751 other toxins from the three-finger toxin (3FTx) and dendrotoxin
families [15]. Yet, whilst such studies present invaluable insights into venom-antivenom inter-
actions, they require expert knowledge in the production and interpretation of microarray
datasets, which limits the wide-spread implementation of hdpm technology in the field of toxi-
nology and, thus, impedes furthering of our understanding of venom-antivenom interactions.
Therefore, in the present study we developed a user-friendly and high-throughput web
application, named “Snake Toxin and Antivenom Binding Profiles” (STAB Profiles), to facili-
tate analyses of hdpm datasets. For the purpose of testing our tool and evaluating its perfor-
mance with a large dataset, we conducted hdpm assays using all African snake toxin protein
sequences available in the UniProt database at the time of study design, together with eight
commercial antivenoms in clinical use in Africa. Furthermore, we introduced a novel method
for evaluating raw signals from a peptide microarray experiment and a data normalization
protocol enabling intra-microarray and even inter-microarray chip comparison. Finally, these
data, alongside all the data from previous similar studies by Engmark et al. [13–15], were pre-
processed according to our newly developed protocol and made publicly available for down-
load through the STAB Profiles web application (http://tropicalpharmacology.com/tools/stab-
profiles/). We hope that this interactive web application and our curated datasets can help
guide the development of increasingly broadly immunoreacting and broadly neutralizing anti-
venoms in the near future by unravelling epitope-paratope interactions and thereby help iden-
tify which epitopes are likely the targets of neutralizing antibodies. Our data does, however,
only represent the first step in such identification, which should be followed up by in vitro and
in vivo validation.
Implementation
The STAB Profiles web application has been created to provide an easy and fast visual identifi-
cation and interpretation of epitope interactions between snake venom toxins and antivenom
antibodies (Fig 1). It uses raw hdpm data to identify the potential presence of linear interaction
sites, based on consecutive peptides producing interaction signals above a Z-score (the number
of standard deviations that the signal distribution is above the noise distribution; if a Z-score is
equal to 0, it is on the mean, whilst if it is equal to +1/-1, it is 1 Standard Deviation above/below
the mean) of 2.5 (p< 0.05). Input data processing is further detailed in the methods section.
PLOS NEGLECTED TROPICAL DISEASES A database for the peptide microarray guided investigation of antivenom cross-reactivity
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008366 June 24, 2020 3 / 20
Fig 1. Schematic overview illustrating the creation and implementation of the Snake Toxin and Antivenom
Binding Profiles (STAB Profiles) web application. (A) Initially, new high-density peptide microarray data was
generated, and the signals were normalized. (B) Thereafter, we created the STAB Profiles web application and allowed
for instant visualization of the data either by “snake venom”, “toxin family”, or “antivenom”. (C) This allows for the
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Binding profile visualization–STAB Profiles
The STAB application supports the investigation of hdpm data and allows the sorting of input
information by antivenom, snake genus, snake species, protein family, protein sub-family, and
protein sub-subfamily. The provided antivenom selection menu is a dropdown menu, where
one can select one or more antivenoms at a time and compare it/them to any snake genus pres-
ent in the database. The comparisons can be further focused via the selection of specific pro-
tein sub-families detected in the specified snake genus. The resultant plots can then be sorted
by snake species or protein family. Furthermore, points of interest can be selected on each plot
and further investigated via the "Chosen Data Points Data Table" tab, which will provide addi-
tional information and the specific amino acid sequence represented by each point, as well as a
data download function.
Interpretation of binding profiles and epitope classification
Each binding profile plot constitutes a single UniProt amino acid sequence for a snake toxin
protein or protein fragment, while every point on a graph represents the interaction signal
between an antivenom antibody and a peptide. A significant pattern, indicating a potential epi-
tope, consists of multiple consecutive peptides with a signal intensity score above the signifi-
cance threshold (2.5, p< 0.05). For the evaluation of toxin-antibody interactions of multiple
antivenoms, it is also of interest to investigate whether similar interaction patterns can be
observed across antivenom profiles. Such consensus would further support the interpretation
of putative signals as representing potentially conserved toxin-antibody interaction sites. This
may possibly hold information about potential cross-reactivity of antivenom antibodies, as
well as antivenom para-specificity, if combined with results from neutralization assays and
antivenomics studies.
Results
In this study, we produced the most comprehensive venom-antivenom hdpm dataset pub-
lished to date and used it to test our newly developed and free to use tool, STAB Profiles. The
results of this process present novel biological insights into venom-antivenom interactions,
antivenom-toxin family coverage, specific linear epitope-antibody interaction sites across mul-
tiple antivenoms, and venom-antivenom interactions for medically relevant toxins.
Description of the design of the microarray experiments
We generated hdpm data using eight polyspecific and widely distributed antivenoms against
African snake species (Table 1) and a 16-mer peptide library derived from 481 toxin protein
sequences (23 protein families from 40 different snake species). Following signal normaliza-
tion, the STAB Profiles were generated in our web application for further analysis.
Snake Toxin and Antivenom Binding Profiles
Assessment of cross-reactivity and of k-mer recognition by the analyzed antivenoms.
When evaluating the STAB Profiles, the first stage of analysis involved the identification of k-
mer interaction sites (peptide sequence of the full toxin protein sequence) for antivenoms that
included the venoms used in their immunization process (proxy for antivenom quality) and
identification and selection of toxin-antibody linear interaction sites. (D) Upon selection of a region of interest the web
application allows further investigation of such interaction sites and provides information about involved k-mers,
position start/end, and signal strength amongst others.
https://doi.org/10.1371/journal.pntd.0008366.g001
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Table 1. Characteristics of the eight African snake antivenoms and two naïve equine serum samples used in the study.
Antivenom name Producer Abbreviation Species venoms neutralized according to
product insert
Active
substance
Viperidae Elapidae
Antivipmyn Africa Instituto Bioclon Bioclon:
Antivipmyn
Bitis arietans
Bitis gabonica
Echis
leucogaster
Echis ocellatus
Echis
pyramidum
Dendroaspis polylepis
Dendroaspis viridis
Naja haje
Naja melanoleuca
Naja nigricollis
Naja pallida
F(ab’)2
EchiTab-Plus-ICP Instituto Clodomiro Picado (ICP) ICP: EchiTab Bitis arietans
Echis ocellatus
Naja nigricollis IgG
Inoserp Panafricain Inosan Biopharma Inosan: Inoserp Bitis arietans
Bitis gabonica
Echis
leucogaster
Echis ocellatus
Echis
pyramidum
Dendroaspis polylepis
Dendroaspis jamesoni
Naja haje
Naja melanoleuca
Naja nigricollis
Naja pallida
F(ab’)2
Snake Venom Antiserum
(Pan Africa)
Premium Serums and Vaccines PSV: Pan Africa Bitis arietans
Bitis gabonica
Bitis nasicornis
Bitis rhinoceros
Echis carinatus
Echis
leucogaster
Echis ocellatus
Dendroaspis polylepis
Dendroaspis jamesoni
Dendroaspis angusticeps
Dendroaspis viridis
Naja haje
Naja melanoleuca
Naja nigricollis
F(ab’)2
FAV-Afrique Sanofi-Pasteur Sanofi Pasteur:
FAV
Bitis arietans
Bitis gabonica
Echis
leucogaster
Echis ocellatus
Dendroaspis polylepis
Dendroaspis jamesoni
Dendroaspis viridis
Naja haje
Naja nigricollis
F(ab’)2
SAIMR (South African Institute for
Medical Research) Polyvalent Snake
Antivenom
South African Vaccine Producers
(SAVP)
SAVP: SAIMR Bitis arietans
Bitis gabonica
Dendroaspis polylepis
Dendroaspis jamesoni
Dendroaspis angusticeps
Hemachatus
haemachatus
Naja annulifera
Naja melanoleuca
Naja mossambica
Naja nivea
F(ab’)2
Snake Venom Antiserum (African) VINS Bioproducts Limited VINS: African Bitis arietans
Bitis gabonica
Echis
leucogaster
Echis ocellatus
Dendroaspis jamesoni
Dendroaspis polylepis
Dendroaspis viridis
Naja haje
Naja melanoleuca
Naja nigricollis
F(ab’)2
Snake Venom Antiserum (Central Africa) VINS Bioproducts Limited VINS: Central
Africa
Bitis gabonica
Daboia russelii
Echis carinatus
Dendroaspis polylepis F(ab’)2
Naïve equine serum sample 1 Instituto Clodomiro Picado (ICP) IgG
Naïve equine serum sample 2 Instituto Clodomiro Picado (ICP) IgG
https://doi.org/10.1371/journal.pntd.0008366.t001
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those that were not (e.g. potential cross-reactivity). Therefore, we expected to see higher levels
of k-mer interaction in antivenoms that also present better in vitro binding and in vivo neutral-
ization, whilst low signals might help identify the need for strategies towards improving the
coverage of a specific antivenom.
We demonstrate that for most species of venomous snakes assessed, SAVP: SAIMR consis-
tently recognized the most k-mers, followed by Sanofi Pasteur: FAV (Fig 1). Conversely, Bio-
clon: Antivipmyn contained the poorest antibody interaction across all analyzed snakes
(Table 1, Fig 2). VINS: African consistently demonstrated poor binding profiles and, surpris-
ingly, was outperformed by its regional-specific sister product, VINS: Central Africa, which
demonstrated recognition of a greater number of k-mers in more species, despite (to the best
of our knowledge) using fewer different venoms during the immunization process (Table 1,
Fig 2). The regional-specific antivenom, ICP: EchiTAB, only demonstrated notable k-mer
interaction to the vipers Echis ocellatus and Bitis arietans–two of three venoms used for immu-
nization. Furthermore, whilst ICP: EchiTAB was superior at recognizing E. ocellatus specific k-
mers compared to all other antivenoms, it demonstrated poor para-specific interaction to
toxin k-mers from other Echis species, as well as Bitis gabonica (Fig 2). Conversely, SAVP:
SAIMR demonstrated a substantial level of para-specific recognition towards k-mers derived
from toxins from E. ocellatus, E. carinatus, and E. p. leakeyi. This was surprising, since SAVP:
SAIMR was the only antivenom in this study not indicated for treating envenoming by Echis
spp. (Fig 1C, Table 1). Furthermore, the results demonstrate that k-mers derived from toxins
Fig 2. Antivenom recognition of the total number of k-mers above the threshold for significance for each snake species. Only venoms which have five or more
toxins represented on the array are depicted. Solid circles represent venoms indicated as being effectively neutralized by an antivenom. Striped circles represent a venom
which is not indicated to be neutralized by an antivenom. Bubble size is proportional to the number of toxins per species represented on the array (determined by No. of
toxins × No. of k-mers).
https://doi.org/10.1371/journal.pntd.0008366.g002
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of the Bitis genus were recognized by all antivenoms to a lesser extent than k-mers from toxins
from other major genera (Dendroaspis, Naja, and Echis) represented on the array (Fig 2). This
is despite the fact that Bitis species toxins were represented in similar numbers as other genera
(Fig 2), and that all antivenoms in this study indicate neutralization of at least one species of
Bitis (Table 1). Notably, we also detected a large degree of para-specific elapid k-mer recogni-
tion by all antivenoms, which was particularly noticeable with N. annulifera and the Asian
cobra N. oxiana toxin-derived k-mers (Fig 2). However, we also found a poor ability of all anti-
venoms in recognizing toxin representative k-mers of certain elapids, e.g. H. haemachatus (Fig
2), with the exception of SAVP: SAIMR, the only antivenom in this study indicated for treating
envenoming by this species.
Peptide interaction signal coverage of antivenoms against major families of
toxin proteins
The data enable the assessment of peptide interaction signal coverage across all eight antiven-
oms vs. dominant (most common and abundant across venomous snakes) and secondary
(common across species, but significantly less abundant than the dominant toxin families)
families of toxins [17]. Notably, out of the dominant toxin families, 3FTxs appeared to consti-
tute the best recognized protein group (particularly cytotoxins), with peptide interaction sig-
nals for PLA2s and SVMPs being markedly lower (Fig 3). This is likely linked, at least in part,
to the fact that 3FTxs were the most abundantly sampled group in this study. On the other
hand, L-amino acid oxidases (LAAOs) and Kunitz-type inhibitors (KUNs) present the best
recognized secondary toxin families, whilst very low signals were recorded for cysteine-rich
secretory proteins (CRISPs) and disintegrins (DISs; Fig 3).
Out of all tested antivenoms SAVP: SAIMR demonstrated the highest peptide interaction
signal coverage against 3FTxs, whilst ICP: EchiTab had the lowest (Fig 3). Conversely, ICP:
EchiTab, together with Inosan: Inoserp, produced the strongest signals against PLA2s and,
together with PSV: Pan Africa, against SVMPs (Fig 3). Meanwhile, most antivenoms produced
poor interaction signals against the majority of the secondary toxin families, with only KUNs
and LAAOs indicating some coverage (Fig 3).
Binding profiles illustrate specific epitope-antibody interaction sites across
multiple antivenoms
Besides generating a general understanding of the cross-reactivity potential and toxin family
coverage of the tested antivenoms, this study also aimed to identify specific toxin epitopes that
interact with antivenom antibodies across species and protein families. The identification of
specific interaction areas of toxins could prove invaluable in the development of specific anti-
toxins and broadly neutralizing next-generation snakebite therapeutics.
Notably, the antivenoms used in this study indicated significant and site-specific interaction
signal consensus, i.e. all or the majority of antivenoms appeared to interact with the same puta-
tive epitope region of a given toxin, rather than each antivenom targeting a different binding
site on the same toxin. Indeed, all tested antivenoms produced significant epitope-antibody
interaction signals against a region consisting of nine subsequent k-mers from a PLA2 (Uni-
Prot ID: Q4QT03) from Bitis arietans (Fig 4A). An equivalent pattern of a specific epitope rec-
ognition site is also found for a PLA2 (UniProt ID: A0A0A1WC82) from Echis coloratus
venom (Fig 4B). Here, all antivenoms, apart from SAVP: SAIMR, exhibited recognition of a
region of 10 consecutive k-mers, despite none of the antivenoms using this venom as an
immunogen, suggesting paraspecific epitope recognition [18]. Contrastingly, we also observed
cases where antibodies from only one antivenom interacted with the target toxin. For example,
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a short neurotoxin (a 3FTx) from H. haemachatus venom (UniProt ID: P01425) only produced
an interaction signal with SAVP: SAIMR (the only antivenom that is made with this venom as
an immunogen; Fig 4C). These findings demonstrate the complexities associated with attempt-
ing to predict antibody binding interactions with often highly variable venom toxins.
Specific epitope-antibody interaction sites across several medically relevant
toxins
This study also illustrated the presence or absence of specific epitope-antibody interaction sites
across a series of clinically important toxins, such as dendrotoxins, PLA2s, and the different
3FTx subclasses of cytotoxins, short neurotoxins, and long neurotoxins [19–21]. These data
enable us to explore and predict the extent to which tested antivenoms may bind and neutral-
ize key, medically relevant toxins.
Fig 3. Bar graphs showing the percentages of significant 16-mer peptide binding signals per toxin family for all snakebite antivenoms
tested in this study. Protein families are divided into dominant (red) and secondary (grey) toxins. The former includes three-finger toxins
(3FTxs), phospholipases A2s (PLA2s), snake venom metalloproteases (SVMPs), and serine proteases (SVSPs), whereas the latter encompasses
L-amino acid oxidases (LAAOs), Kunitz-type inhibitors (KUNs), cysteine-rich secretory proteins (CRISPs), glycosyl hydrolases (GHs), nerve
growth factor beta (NGF beta), disintegrins (DISs), natriuretic peptides (NPs), and snake C-type lectins (Snaclecs). The numbers in brackets
next to the toxin family names are the total number of 16-mer peptides used in the analysis for each protein family and the number of
UniProt protein sequences the peptides per protein family were derived from.
https://doi.org/10.1371/journal.pntd.0008366.g003
Fig 4. Screenshots from the STAB Profiles web application of three different types of toxin-antivenom interaction signals detected. (top) an interaction
site recognized by antibodies from all antivenoms for a toxin used in the immunization mixtures (B. arietans PLA2 Q4QT03), (middle) an interaction site
recognized by antibodies from all antivenoms for a toxin not used in the immunization mixtures (E. coloratus PLA2 A0A0A1WC82), and (bottom) an
interaction site recognized by antibodies from only one antivenom for a toxin used in its immunization mixture (H. haemachatus short 3FTx neurotoxin
P01425). Referred to sites of interaction are marked with a red square and the dotted line indicates the signal significance cutoff.
https://doi.org/10.1371/journal.pntd.0008366.g004
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Dendrotoxins
We found that dendrotoxins from D. polylepis and D. angusticeps were poorly recognized by
all antivenoms. PSV: Pan Africa presented the best, yet still poor, interaction signals against
dendrotoxin I (P00979; Dendroaspis polylepis) and alpha-dendrotoxin (P00980; D. angusticeps;
Fig 5). However, even though PSV: Pan Africa constitutes the only tested antivenom that
included all four species of mambas in its immunizing mixture (D. polylepis, D. angusticeps, D.
jamesoni, and D. viridis), the interaction signals against dendrotoxin I and alpha-dendrotoxin
barely surpassed the significance threshold (Fig 5).
3FTxs: Cytotoxins
The interaction signals produced by antivenoms and six cytotoxins from two different
spitting cobra species (Naja pallida and N. mossambica) were low, with cytotoxins 2, 3, and 5
(N. mossambica) indicating no signal at all (Fig 6). Cytotoxin 1 (P01468 and P01467) from
both cobras and cytotoxin 4 (P01452) from N. mossambica presented signals above the signifi-
cance threshold (Fig 6), despite neither of these venoms being used in the immunization pro-
cess for the majority of the tested antivenoms. Notably, these data indicate that some snake
venom cytotoxins are potentially conserved across cobras, whereas others are more species-
specific.
3FTxs: Long and short neurotoxins
Interaction signals between the eight antivenoms and both short and long neurotoxins were
assessed in this study. The investigation of two long and four short neurotoxins from four dif-
ferent species of snakes (Naja and Dendroaspis spp.) against the various antivenoms indicated
Fig 5. Dendrotoxin-antivenom interaction signals detected across all eight tested antivenoms.
https://doi.org/10.1371/journal.pntd.0008366.g005
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common epitopes across most of the short neurotoxins (15AA to 30AA; Fig 7); though, many
of these sites barely surpassed the significance threshold. For the long neurotoxins, the only
unique profile that we observed was between SAVP: SAIMR and long neurotoxin 2 (P01383)
from Naja melanoleuca (Fig 7).
Discussion
In this study we produced the most comprehensive venom-antivenom hdpm dataset to date
[13–15], including eight polyspecific antivenoms and a peptide library derived from toxin pro-
tein sequences representing 40 snake species and 481 proteins from 23 protein families. Due to
Fig 6. Cytotoxin-antivenom interaction signals detected across all eight tested antivenoms.
https://doi.org/10.1371/journal.pntd.0008366.g006
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the expertise and time typically required to analyze data of comparable quantity [13–15], we
have generated a free-to-use, user-friendly web application (STAB Profiles: http://
tropicalpharmacology.com/tools/stab-profiles/) that enables easy access to all data generated
in this study, in addition to all previously published venom-antivenom hdpm datasets.
Through the use of the STAB Profiles web application, we were able to analyze the substantial
amount of antibody-venom toxin binding profiles generated with relative ease, allowing rapid
identification of specific venom-antivenom interactions simultaneously across different spe-
cies of venomous snakes and diverse toxin families.
Our STAB Profiles web application allowed us to investigate to what extent different anti-
venoms interact with linear elements of epitopes from dominant and secondary toxin families
[17]. We discovered that 3FTxs were the most bound toxin family out of all tested dominant
toxins, with peptide interaction signals for phospholipase A2s (PLA2s) and metalloproteases
(SVMPs) being markedly lower. The interaction with 3FTxs is of particular importance given
their abundance, especially in elapids, and their high levels of toxicity [22]. In our study, we
found that SAVP: SAIMR presented the highest peptide interaction signal coverage against
this family of toxins. This is unsurprising, since it has been previously demonstrated that this
antivenom displayed strong binding signals against 3FTxs when tested against whole venom
from Dendroaspis polylepis [21], Dendroaspis angusticeps [19], and Naja melanoleuca [20].
Nevertheless, when tested in vivo, Lauridsen et al. found that lethality and overall toxicity were
only neutralized at high anitivenom/venom ratios (e.g. 1.0 mg/mL in D. angusticeps); this indi-
cated that even antivenoms with high peptide interaction signal coverage might not sufficiently
neutralize 3FTxs [19–21]. These data present intriguing insights into the ability of antivenom
antibodies to bind to specific toxin families.
We also aimed to identify linear toxin epitopic elements for antivenom antibodies across
species and protein families. Whilst conformational epitopes could also be important to con-
sider, linear epitopic elements are easier to reproduce and have been shown to often success-
fully approximate their true conformational epitopes [23–25]. The STAB Profiles web
application can be used to rapidly identify potential linear epitopes and compare the epitope
recognition ability of different antivenoms. One of the most notable findings we made is that
antivenoms do not appear to recognize unique epitopes, and instead most seem to bind the
same epitope, even when paraspecific. This immunodominance phenomenon is of particular
interest when considering the development of targeted anti-toxin therapeutics that could be
targeted towards the same epitopes.
Another finding with potential clinical implications, is the apparent lack or poor ability of
some antivenoms to recognize peptides from key, medically relevant toxins (i.e. dendrotoxins
(Dendroaspis spp.; [19, 21]), cytotoxins [26], short neurotoxins [19–21], and long neurotoxins
[20]). We found that the majority of these toxins were very poorly recognized or not recog-
nized at all, which is in line with reports from previous toxicovenomic studies that also suggest
poor neutralization of these types of toxins [19–21, 27]. The reason for the poor recognition of
these toxins by the antivenom antibodies on the hdpm could be caused by this group of toxins
being neutralized via conformational epitopes. However, the lack of recognitions could also be
linked to their low immunogenicity [28] and high diversity. Consequently, the high levels of
toxicity of some of these toxins, together with the increasing evidence of poor recognizing and
neutralizing capacity of antivenoms against these components, requires innovative approaches
to improve the immunogenicity of low molecular weight toxins during manufacture. Fortu-
nately, the use of neurotoxin-enriched venom mixtures for immunization [29] and recent
advances towards next-generation therapeutics (e.g. recombinant oligoclonal antivenoms)
might present some solutions for this problem, as well as help improve paraspecificity towards
a wider range of venoms [18, 30, 31].
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Fig 7. Neurotoxin-antivenom interaction signals detected across all eight tested antivenoms.
https://doi.org/10.1371/journal.pntd.0008366.g007
PLOS NEGLECTED TROPICAL DISEASES A database for the peptide microarray guided investigation of antivenom cross-reactivity
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008366 June 24, 2020 14 / 20
Whilst this study and the STAB Profiles web application have provided valuable new
insights and will likely continue to do so in the future it is important to note that this approach
has limitations. The conclusions that can be drawn from our web application are only as good
as the data provided and while we aimed to ensure high standards throughout the data produc-
tion and building of the web application, some venom toxins of certain species are better rep-
resented than others. Furthermore, batch-to-batch variations of the antivenoms could also
distort some insights gained. Finally, the absence of a signal does not necessarily imply an
inability to bind toxins, since binding might occur to conformational epitopes without strong
linear epitopic elements. Indeed, we do not know the relative number of epitopes that encom-
pass linear elements, large enough to be identified via hdpm. However, findings from previous
studies indicate that the epitopes typically coincide with the functional sites of toxins [13].
Overall, we believe that as long as its limitations are considered, the STAB Profiles web applica-
tion has the potential to play a significant role in understanding current antivenoms better, but
also aid in the development of entirely new antivenom technologies.
Conclusions
The considerable amount of venom toxin and antivenom antibody interaction data presented
in this paper, in combination with the free and easy to use STAB Profiles web application, has
the potential to be of substantial value to the venom-antivenom research community. The
dataset and STAB Profiles web application have already helped gain insights into snake toxin
epitopes and paraspecific binding capacities of African antivenoms. We encourage researches
to use the data and STAB Profiles web application to help guide the improvement and optimi-
zation of current antivenoms for broader and increased therapeutic coverage. Furthermore,
we believe that the data presented here will be crucial to the development and rapid assessment
of next-generation broadly neutralizing antivenoms via the identification and characterization
of relevant target epitopes for toxin neutralization.
Methods
Antivenoms and negative controls
Eight lyophilized polyspecific antivenoms were evaluated: (a) Antivipmyn Africa produced by
Instituto Bioclon S.A. de C.V., Mexico City, Mexico (batch number DFB-150903, expiration
date 09–2020) (Bioclon: Antivipmyn), (b) EchiTab-Plus-ICP produced by Instituto Clodo-
miro Picado (ICP), San Jose´, Costa Rica (batch number 5370114PALQ, expiration date 01–
2017) (ICP: EchiTab), (c) Inoserp Panafricain produced by Inosan Biopharma, S.A., Madrid,
Spain (batch number 2VT08001, expiration date 08–2015) (Inosan: Inoserp), (d) Snake
Venom Antiserum (Pan Africa) produced by Premium Serums and Vaccines Pvt. Ltd. (PSV),
Maharashtra, India (batch number 062003, expiration date 01–2018) (PSV: Pan Africa), (e)
FAV-Afrique produced by Sanofi-Pasteur SA, Lyon, France, (batch number K8453-1, expira-
tion date 06–2016) (Sanofi Pasteur: FAV), (f) SAIMR (South African Institute for Medical
Research) Polyvalent Snake Antivenom produced by South African Vaccine Producers
(SAVP) (Pty) Ltd., Sandringham, South Africa (batch number BC02645, expiration date 07–
2016) (SAVP: SAIMR), (g) Snake Venom Antiserum (African) produced by VINS Biopro-
ducts Limited, Telangana, India (batch number 13022, expiration date 01–2018) (VINS: Afri-
can), and (h) Snake Venom Antiserum (Central Africa) produced by VINS Bioproducts
Limited, Telangana, India (batch number 12AS13002, expiration date 04–2017) (VINS: Cen-
tral Africa). All antivenoms are of equine origin and a list of snake species they are meant to
neutralize is provided in Table 1. A sample of naïve equine whole IgG purified from the plasma
of horses that had not been immunized with venoms was obtained from Instituto Clodomiro
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Picado (ICP), San Jose´, Costa Rica, and used as negative control. Prior to further use, all anti-
venom samples were diluted to the same protein concentration (22.17 mg/ml).
In silico design of high-density peptide microarrays
A library of unique 16-mer peptides was designed in silico for microarray synthesis. The
library comprised peptides derived from toxin protein sequences representing 40 snake
species and 481 (447 Swiss-Prot reviewed) proteins representing 23 protein families. Protein
fasta files were downloaded from the UniProt database, the sequences were trimmed for signal
peptides and all unknown amino acid residues (X) were substituted by comparison with
homologue protein sequences also included in the study. The 16-mer peptides were then con-
structed by splitting all toxins into k-mers of 16 amino acids by tiling at every amino acid
position.
Furthermore, for all the peptides generated from secreted African snake venom toxin
sequences, the library was extended to include peptides from an alanine scan substitution. The
alanine scan was generated by substituting every second amino acid in each peptide with ala-
nine as well as including a special alanine mutation peptide for 4 peptides to improve the dept
of the data resulting in at least two substitutions for each residue, except the two terminal resi-
dues. The peptide library including the alanine scan finalized at a total of 164,255 peptides,
which were then filtered to remove redundant peptides, resulting in a total of 163,254 unique
peptides. A subset of 2,172 peptides were randomly selected from the library and replicated
four times to check for correspondence in signal variances with the possibility of calculating
the median of the standard deviation (SD) as a function of signal strength, which could in turn
be used to calculate SD for peptide signals with only a single replicate. Lastly, an additional
1,001 completely random peptides were included in the library as negative controls for back-
ground peptide-antibody interaction noise, resulting in a total of 172,943 peptides included in
each microarray. The final hdpm design was generated by assigning all peptides in the library
random positions.
Peptide microarray hybridization, sample binding, and processing
Three identical custom designed Roche NimbleGen 12-plex (12x135K) chamber microarray
chips were synthesized by the Roche NimbleGen Peptide Lab in Madison, WI, USA. These
three chips each included 12 identical microarray chambers, resulting in a total of 36 identical
microarrays, which were synthesized with a Roche-NimbleGen Maskless Array Synthesiser
(MAS). The MAS system uses light-directed solid-phase peptide synthesis, described as an
amino-functionalized surface coupled with a 6-aminohexanoic acid linker and amino acid
derivatives carrying a photosensitive 2-(2-nitrophenyl)propyloxycarbonyl (NPPOC) protec-
tion group. Amino acid coupling was performed for 3 minutes in dimethylformamide (DMF),
using amino acids pre-activated with 2-(1H-benzotriazol-1-yl)-1,1,3,3,-tetramethyluronium
hexafluorophosphate (HBTU) as an activator, hydroxybenzotriazole (HOBt) to suppress race-
mization, and N,N-diisopropylethylamine as base. The microarray was washed with N-
methyl-2-pyrrolidone (NMP) following each coupling step. Site-specific cleavage of the
NPPOC protection group was done by irradiation of an image created by a Digital Micro-Mir-
ror Device (Texas Instruments, SXGA + graphics format), projecting light at a 365 nm wave-
length. Coupling cycles were repeated to synthesize the full in silico generated peptide library.
Treatment with 95% trifluoroacetic acid/4.5% water/0.5% triisopropylsilane for 30 min was
used for final removal of side-chain protection groups.
All 12 microarray chambers on each of the three chips were incubated overnight at 4˚C
with chamber specific antivenom samples, one of the naïve equine serum negative control
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samples, or a pure binding buffer negative control sample. The first 12-plex chip had a micro-
array chamber with each of the 8 antivenom samples and the first naïve equine serum negative
control sample mixed with binding buffer at a 1:250 dilution, two microarray chambers with
the Sanofi Pasteur: FAV antivenom from at a 1:100 and 1:1000 dilution, respectively, and one
microarray chamber with only the pure binding buffer negative control sample, resulting in a
total fluid volume of 100 μL per microarray chamber. The second and third 12-plex chips had
a microarray chamber with each of the 8 antivenom samples and the second naïve equine
serum negative control sample at a 1:250 dilution, two additional microarray chambers with
the second naïve equine serum negative control sample at a 1:2500 and 1:10000 dilution,
respectively, and one microarray chamber with only the pure binding buffer negative control
sample. This was followed by three washes, each of 10 minutes duration, with a Tris Buffered
Saline and Tween 20 (TBST) buffer and incubation at room temperature for 3 hours with
Alexa Flour 647-conjugated AffiniPure Goat Anti-Horse IgG (H+L) (Jackson ImmunoRe-
search Laboratories, Inc., PA, USA, code no. 108-605-003, lot no. 102264). After a final wash,
the microarrays were dried and read using a MS200 microarray scanner, and signals were
extracted using the NimbleGen DEVA signal extraction software, as also described by Eng-
mark et al. [13].
Signal normalization and classification of significant signals
Classification of peptides as binders or non-binders was based on the signal intensity. Before
this classification, all signals were normalized with the purpose of determining a threshold for
signal significance. First, signal values were cleaned for potential background noise. Evaluating
one chip at a time, the position-specific signal observed in the sector evaluated with buffer as
the primary antibody were subtracted from signals observed in sectors evaluating antivenom
as primary antibody. This correction removed potential false-positive signals, as a result of
non-specific secondary antibody binding. After cleaning of false positive signals, all peptide
interaction signals were log transformed, resulting in a closer to normal distribution. For sig-
nal normalization the signals of the subset of 1,001 completely random peptides from all
microarrays on every chip were used to calculate mean and standard deviation (SD) per chip.
All non-random peptides per chip were then scaled by subtracting the calculated mean and
dividing by the calculated SD. After normalization, peptide signals were represented by Z-
score, and peptides with a normalized signal score higher than 2.5 (corresponding to a p-value
of maximum 0.05) were considered significant. The 2,172 peptides present in replicates were
represented by the median signal score, resulting in one signal score per peptide. All Perl
scripts used in data treatment were made available through Mendeley data (http://dx.doi.org/
10.17632/v88xfw5wyx.2), with the purpose of making our normalization strategy freely avail-
able to anyone wanting to work with the data in the future.
Construction of Snake Toxin and Antivenom Binding Profiles (STAB
Profiles)
Peptide to toxin affiliation was obtained by performing local alignment using BLASTp
[32], for all peptides as well as a selection of toxin sequences representing the geographical
region of Africa (305 proteins). The local alignment results were filtered and only alignments
representing a 100% identity, no gaps, and an alignment length of 16 amino acids were consid-
ered in the further analysis (alanine scan results and sensitivity to mutations were not evalu-
ated in this study, but have been included in the available dataset found at Mendeley data
(http://dx.doi.org/10.17632/v88xfw5wyx.2; link also available in the STAB Profiles web
application).
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The binding profiles were constructed by assigning the interaction signal to the protein
sequence position representing the beginning of the alignment. The position-specific score
symbolized the interaction intensity for the following 16-amino acid peptide. As eight antiven-
oms were evaluated, all positions with a signal were represented by eight signal scores, each
specific to the primary antivenom antibodies used in incubation.
Binding profiles were generated as diagrams of the 16-mer starting position in alignment of
the total amino acid protein position on the x-axis and the normalized signal intensity on the
y-axis. In this visualization, the full amino acid sequences are represented, and the observed
interaction sites are illustrated as a peak in the graph. The entire data processing was per-
formed using custom-built Perl scripts.
Building the web application
The interactive web application was constructed using the R package “Shiny” [33] in RStudio
v1.1.453 (RStudio Team, 2016) with R v3.5.0 (R Core Team, 2018). Shiny is used for turning
analyses created with R into interactive web applications without the programmer requiring
further knowledge of HTML, JavaScript, or CSS web programming. Shiny is intended to
deliver interactive experiences that provide the end users with the option of changing input
values on a webpage and having the results of an R program being written as output values
back out to the web page in a reproducible way. It therefore allows the end user to have an
interactive experience with the data available in the app in a simple and intuitive manner with-
out the user being able to change the original data.
The STAB Profiles web application was built from three components; the user interface
(UI) as a UI object controlling the layout and appearance of the application, a server function
containing instructions needed to build the application, and a call to the “shinyApp” function,
which combines the UI and server parts to create the Shiny web application object on the basis
of the hdpm data described above. The UI object was designed to create the most intuitive and
user-friendly interface for the application end user. The server function was built to subset the
loaded snake toxin and antivenom binding data on the basis of the user’s selected input choices
(antivenom(s), snake genus, snake species, protein family, protein sub-family, protein sub-
sub-family) and visually display the subsetted data as one or more line-graphs in interactive
plots using the R package “ggplot2” [34]. The interactive ggplots make it possible for the end
user to choose specific points of interest on the graphs, which are then displayed in a HTML
table widget as a downloadable csv-file using the “datatable” function from the “DT” [35] R
package. The R package “dplyr” [36] was used for data wrangling and the subsetted data was
also made available in a HTML table widget as a downloadable csv-file. Colors representing
different antivenoms in the interactive plots were manually defined together with plot axes
limits and a number of other visual specifications.
Author Contributions
Conceptualization: Mikael Engmark, Bruno Lomonte, Julia´n Ferna´ndez, Jose´ M. Gutie´rrez,
Ole Lund, Andreas H. Laustsen.
Data curation: Kamille E. Krause, Timothy P. Jenkins, Carina Skaarup.
Formal analysis: Kamille E. Krause, Timothy P. Jenkins, Carina Skaarup, Stuart Ainsworth.
Funding acquisition: Mikael Engmark, Nicholas R. Casewell, Stuart Ainsworth, Ole Lund,
Andreas H. Laustsen.
Investigation: Kamille E. Krause, Timothy P. Jenkins, Carina Skaarup, Stuart Ainsworth.
PLOS NEGLECTED TROPICAL DISEASES A database for the peptide microarray guided investigation of antivenom cross-reactivity
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008366 June 24, 2020 18 / 20
Methodology: Mikael Engmark, Nicholas R. Casewell, Ole Lund.
Project administration: Mikael Engmark, Ole Lund, Andreas H. Laustsen.
Resources: Mikael Engmark, Bruno Lomonte, Julia´n Ferna´ndez, Jose´ M. Gutie´rrez, Ole Lund,
Andreas H. Laustsen.
Software: Kamille E. Krause, Carina Skaarup.
Supervision: Mikael Engmark, Ole Lund, Andreas H. Laustsen.
Validation: Kamille E. Krause, Carina Skaarup, Mikael Engmark, Ole Lund.
Visualization: Kamille E. Krause, Timothy P. Jenkins, Stuart Ainsworth.
References
1. Chippaux JP. Snakebite envenomation turns again into a neglected tropical disease! J Venom Anim
Toxins Trop Dis. 2017; 23. https://doi.org/10.1186/s40409-017-0127-6 PMID: 28804495
2. Gutie´rrez JM, Calvete JJ, Habib AG, Harrison RA, Williams DJ, Warrell DA. Snakebite envenoming.
Nat Rev Dis Primer. 2017; 3:17063. https://doi.org/10.1038/nrdp.2017.63 PMID: 28905944
3. Gutie´rrez JM, Solano G, Pla D, Herrera M, Segura A´ , Vargas M, et al. Preclinical Evaluation of the Effi-
cacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead. Toxins. 2017;
9. https://doi.org/10.3390/toxins9050163 PMID: 28505100
4. Gutie´rrez JM, Leon G, Lomonte B, Angulo Y. Antivenoms for Snakebite Envenomings. Inflamm Allergy
Drug Targets. 2011; 10:369–80. https://doi.org/10.2174/187152811797200669 PMID: 21745181
5. Jenkins TP, Fryer T, Dehli RI, Ju¨rgensen JA, Fuglsang-Madsen A, Føns S, et al. Toxin Neutralization
Using Alternative Binding Proteins. Toxins. 2019; 11:53. https://doi.org/10.3390/toxins11010053 PMID:
30658491
6. Laustsen AH, Engmark M, Milbo C, Johannesen J, Lomonte B, Lohse JMG and B. From Fangs to Phar-
macology: The Future of Snakebite Envenoming Therapy. Current Pharmaceutical Design. 2016;
22:5270–5293. https://doi.org/10.2174/1381612822666160623073438 PMID: 27339430
7. Calvete JJ, Arias AS, Rodrı´guez Y, Quesada-Bernat S, Sa´nchez LV, Chippaux JP, et al. Preclinical
evaluation of three polyspecific antivenoms against the venom of Echis ocellatus: Neutralization of toxic
activities and antivenomics. Toxicon. 2016; 119:280–8. https://doi.org/10.1016/j.toxicon.2016.06.022
PMID: 27377229
8. Gutie´rrez JM, Lomonte B, Leo´n G, Alape-Giro´n A, Flores-Dı´az M, Sanz L, et al. Snake venomics and
antivenomics: Proteomic tools in the design and control of antivenoms for the treatment of snakebite
envenoming. Venomics. J Proteomics. 2009; 72:165–82. https://doi.org/10.1016/j.jprot.2009.01.008
PMID: 19344652
9. Laustsen AH, Lohse B, Lomonte B, Engmark M, Gutie´rrez JM. Selecting key toxins for focused devel-
opment of elapid snake antivenoms and inhibitors guided by a Toxicity Score. Toxicon. 2015; 104:43–
45. https://doi.org/10.1016/j.toxicon.2015.07.334 PMID: 26238171
10. Calvete JJ, Rodrı´guez Y, Quesada-Bernat S, Pla D. Toxin-resolved antivenomics-guided assessment
of the immunorecognition landscape of antivenoms. Toxicon. 2018; 148:107–122. https://doi.org/10.
1016/j.toxicon.2018.04.015 PMID: 29704534
11. Laustsen AH. Guiding recombinant antivenom development by omics technologies. N Biotechnol.
2018; 45:19–27. https://doi.org/10.1016/j.nbt.2017.05.005 PMID: 28552814
12. Ledsgaard L, Jenkins TP, Davidsen K, Krause KE, Martos-Esteban A, Engmark M, et al. Antibody
Cross-Reactivity in Antivenom Research. Toxins. 2018; 10:393. https://doi.org/10.3390/
toxins10100393 PMID: 30261694
13. Engmark M, Andersen MR, Laustsen AH, Patel J, Sullivan E, De Masi F, et al. High-throughput
immuno-profiling of mamba (Dendroaspis) venom toxin epitopes using high-density peptide microar-
rays. Sci Rep. 2016; 6:36629. https://doi.org/10.1038/srep36629 PMID: 27824133
14. Engmark M, Lomonte B, Gutie´rrez JM, Laustsen AH, Masi FD, Andersen MR, et al. Cross-recognition
of a pit viper (Crotalinae) polyspecific antivenom explored through high-density peptide microarray epi-
tope mapping. PLoS Negl Trop Dis. 2017; 11:e0005768. https://doi.org/10.1371/journal.pntd.0005768
PMID: 28708892
15. Engmark M, Jespersen MC, Lomonte B, Lund O, Laustsen AH. High-density peptide microarray explo-
ration of the antibody response in a rabbit immunized with a neurotoxic venom fraction. Toxicon. 2017;
138:151–158. https://doi.org/10.1016/j.toxicon.2017.08.028 PMID: 28867663
PLOS NEGLECTED TROPICAL DISEASES A database for the peptide microarray guided investigation of antivenom cross-reactivity
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008366 June 24, 2020 19 / 20
16. Meng X, Wei J, Wang Y, Zhang H, Wang Z. The role of peptide microarrays in biomedical research.
Anal Methods. 2018; 10:4614–24. https://doi.org/10.1039/C8AY01442F
17. Tasoulis T, Isbister GK. A Review and Database of Snake Venom Proteomes. Toxins. 2017; 9:290.
https://doi.org/10.3390/toxins9090290 PMID: 28927001
18. Ainsworth S, Slagboom J, Alomran N, Pla D, Alhamdi Y, King SI, et al. The paraspecific neutralisation
of snake venom induced coagulopathy by antivenoms. Commun Biol. 2018; 1:34. https://doi.org/10.
1038/s42003-018-0039-1 PMID: 30271920
19. Lauridsen LP, Laustsen AH, Lomonte B, Gutie´rrez JM. Toxicovenomics and antivenom profiling of the
Eastern green mamba snake (Dendroaspis angusticeps). J Proteomics. 2016; 136:248–61. https://doi.
org/10.1016/j.jprot.2016.02.003 PMID: 26877184
20. Lauridsen LP, Laustsen AH, Lomonte B, Gutie´rrez JM. Exploring the venom of the forest cobra snake:
Toxicovenomics and antivenom profiling of Naja melanoleuca. J Proteomics. 2017; 150:98–108.
https://doi.org/10.1016/j.jprot.2016.08.024 PMID: 27593527
21. Laustsen AH, Lomonte B, Lohse B, Ferna´ndez J, Gutie´rrez JM. Unveiling the nature of black mamba
(Dendroaspis polylepis) venom through venomics and antivenom immunoprofiling: Identification of key
toxin targets for antivenom development. J Proteomics. 2015; 119:126–42. https://doi.org/10.1016/j.
jprot.2015.02.002 PMID: 25688917
22. Kini RM, Doley R. Structure, function and evolution of three-finger toxins: Mini proteins with multiple tar-
gets. Toxicon. 2010; 56:855–67. https://doi.org/10.1016/j.toxicon.2010.07.010 PMID: 20670641
23. Forsstro¨m B, Axna¨s BB, Rockberg J, Danielsson H, Bohlin A, Uhlen M. Dissecting antibodies with
regards to linear and conformational epitopes. PLoS One. 2015; 10: e0121673. https://doi.org/10.1371/
journal.pone.0121673 PMID: 25816293
24. Pellequer JL, Westhof E, Van Regenmortel MHV. [8] Predicting location of continuous epitopes in pro-
teins from their primary structures. In: Methods in Enzymology. Academic Press; 1991. p. 176–201.
https://doi.org/10.1016/0076-6879(91)03010-e PMID: 1722270
25. Moskalenko M, Chen L, Roey M van, Donahue BA, Snyder RO, McArthur JG, et al. Epitope Mapping of
Human Anti-Adeno-Associated Virus Type 2 Neutralizing Antibodies: Implications for Gene Therapy
and Virus Structure. J Virol. 2000; 74:1761–6. https://doi.org/10.1128/jvi.74.4.1761-1766.2000 PMID:
10644347
26. Panagides N, Jackson TNW, Ikonomopoulou MP, Arbuckle K, Pretzler R, Yang DC, et al. How the
Cobra Got Its Flesh-Eating Venom: Cytotoxicity as a Defensive Innovation and Its Co-Evolution with
Hooding, Aposematic Marking, and Spitting. Toxins. 2017; 9:103. https://doi.org/10.3390/
toxins9030103 PMID: 28335411
27. Laustsen AH, Gutie´rrez JM, Lohse B, Rasmussen AR, Ferna´ndez J, Milbo C, Lomonte B. Snake
venomics of monocled cobra (Naja kaouthia) and investigation of human IgG response against venom
toxins. Toxicon. 2015; 99:23–35. https://doi.org/10.1016/j.toxicon.2015.03.001 PMID: 25771242
28. Tanaka GD, Sant’Anna OA, Marcelino JR, Lustoza da Luz AC, Teixeira da Rocha MM, Tambourgi DV.
Micrurus snake species: Venom immunogenicity, antiserum cross-reactivity and neutralization poten-
tial. Toxicon. 2016; 117:59–68. https://doi.org/10.1016/j.toxicon.2016.03.020 PMID: 27045363
29. Ratanabanangkoon K, Tan KY, Eursakun S, Tan CH, Simsiriwong P, Pamornsakda T, et al. A Simple
and Novel Strategy for the Production of a Pan-specific Antiserum against Elapid Snakes of Asia. PLoS
Negl Trop Dis. 2016; 10. https://doi.org/10.1371/journal.pntd.0004565 PMID: 27058956
30. Laustsen AH, Karatt-Vellatt A, Masters EW, Arias AS, Pus U, Knudsen C, et al. In vivo neutralization of
dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies. Nat
Commun. 2018; 9:3928. https://doi.org/10.1038/s41467-018-06086-4 PMID: 30279409
31. de la Rosa G, Olvera F, Archundia IG, Lomonte B, Alago´n A, Corzo G. Horse immunization with short-
chain consensus α-neurotoxin generates antibodies against broad spectrum of elapid venomous spe-
cies. Nat Commun. 2019; 10:1–8. https://doi.org/10.1038/s41467-018-07882-8 PMID: 30602773
32. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol.
1990; 215:403–10. https://doi.org/10.1016/S0022-2836(05)80360-2 PMID: 2231712
33. Chang W, Cheng J, Allaire J, Xie Y, McPherson J. shiny: Web application framework for r, 2015. R
Package Version. 2018; 1:14.
34. Wickham H, Chang W. ggplot2: An implementation of the Grammar of Graphics. R package version
0.8. 3. 2009.
35. Xie Y, Allaire JJ, Grolemund G. R markdown: The definitive guide. Chapman and Hall/CRC; 2018.
36. Wickham H, Francois R, Henry L. Mu¨ller K. dplyr: A Grammar of Data Manipulation. R package version
0.7. 6. 2018.
PLOS NEGLECTED TROPICAL DISEASES A database for the peptide microarray guided investigation of antivenom cross-reactivity
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008366 June 24, 2020 20 / 20
